Member Info for Muck165

Agree. The man can be seen here https://www.linkedin.com/in/daniel-palsager-69a001174/?originalSubdomain=uk

The dog is yet to be recruited by the company

Mediport Limited

https://find-and-update.company-information.service.gov.uk/company/13126236

Incorporated 11/1/21

Ha - thanks Gkb47. Feel suitably useless!

well I have spent a little time looking at this and, in summary, think its croc.

Can't find any website for a company called MediPort diagnostics
Lets face it, the link I posted is littered with spelling and grammatical errors. It almost feels like one of those spam e-mails we all get pretending to be real and asking for bank details.
The referees they named from high end customers don't actually appear to be in quite the roles proclaimed

Could be wrong, but I'm not getting excited by it.

Make that closer to 9:1 buys to sells now that the late reported trades are going through!

Would be nice to get affimation soon, and for there to be plenty more delivery drivers and much bigger trucks!

Anyone else confused by the lacklustre SP movement here? Buy volumes were 6-7 times sell volumes today and so I can only assume that;

- We need greater overall volume to drive the SP (which "affimation" would help with!)
- We still have a seller, though who that is given the lock ins remains a mystery.

Any illuminating thoughts anyone??

Whatever, I bought more today and still think that with the low free float and low comparative MCAP, any decent news will take the shackles off this. And news cannot be far away, on multiple fronts.

perhaps ignore that - its 11 years old!!!

I was wondering the same - this is worth a quick read

https://www.pinsentmasons.com/out-law/guides/the-model-code-on-share-dealing

Thanks Mardler.

Do you know who owns the IP to the test?

https://www.scci.org.uk/Data/News_Downloads/UOP_Mediport_RapidTestKit_PDF.pdf?date=16/02/2021%2019:05:00

Am still trying to find out more....

Tend to agree AJ.

We know ABDX have continued to make and stockpile ABC-19, but I don’t know if any other RTC partners have. I’m assuming that if ABDX can secure sales itself, or through its own distribution partners, then it will be entitled to fill 100% of those orders itself (and bank 100% of the profit). We only need the other RTC partners if we don’t have manufacturing capacity (or stock) to fill orders.

But who knows!

Do Abingdon own the IP to this test, or do the RTC?

AM confused, because the trademarks are registered with an ABDX subsid which has no links to other RTC members.

Is it the case that ANY orders for ABC-19, whether to the govt or commercially, must be split between the RTC members, or is it the case that each of those members are free to make and sell them independently of each other, and to retain whatever profit they make from independent sales?

Someone's buying now!!

Published today

https://uspto.report/TM/88896035/PB320210406025659/

Courtesy of Gazza on twitter

True, but the MMs won’t make anything if the spread is too high and puts investors off.

For info, here are the current Covid Elisa tests in the Abcam Catalogue

https://www.abcam.com/products?keywords=covid+elisa

Generally speaking, these are offered at c$10 per reaction ($960 for a 96 plate)

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/975919/20210405_Roadmap_Reviews_-_Update_-_standard_size_-_FINAL.pdf

Surescreen saliva test uses a funnel - video here.

https://www.surescreen.com/products/covid-19-coronavirus-antigen-saliva-cassette

Surescreen

MD - agree with you. You mentioned Chile, but India is another example - they experienced a 1st wave peaking at circa 100k cases a day, but are now well into their second, with cases rocketing from less than 25k at the beginning of March to over 100k now. Given the second wave experience of European countries, and the staggering recent rate of increase in India, the second wave potential in India doesn’t bear thinking about.

https://timesofindia.indiatimes.com/india/covid-vaccine-why-indias-second-wave-has-sparked-global-concerns/articleshow/81900973.cms